Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jorke

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Archiv Fur Geschwulstforschung|January 1, 1988
Results of treating stage III and IV malignant non-Hodgkin's lymphomas (NHL)H Jahn, K Ruffert, G Syrbe, et al.
Gastroenterologisches Journal : Organ Der Gesellschaft Fur Gastroenterologie Der DDR|January 1, 1989
[Resorption and biotransformation of model substances in primary idiopathic hemochromatosis (siderophilia)]A Hoffmann, A Müller, M Reinhardt, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[Epidemiology of hormone dependent malignant tumors--ovulation inhibitors and liver tumors]M Bergmann, D Jorke, G Machnik, et al.
Gastroenterologisches Journal : Organ Der Gesellschaft Fur Gastroenterologie Der DDR|January 1, 1989
[Biotransformation in patients following Depressan-induced hepatitis]A Hoffmann, M Reinhardt, C Rechenbach, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1981
[Malignant lymphomas: involvement and complications of the gastro-intestinal tract (author's transl)]D Jorke, H Jahn, K Ruffert, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1988
Enzyme activities of collagen peptidase (CP), monoaminoxidase (MAO) and N-acetyl-beta-D-glucosaminidase (beta-NAG) as fibrosis marker in chronic liver diseasesA Müller, C Zollmann, G Machnik, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1985
Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosisA Traeger, R Häntze, M Penzlin, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1985
[Emergency endoscopy in chronic liver diseases]J Truckenbrodt, H Bosseckert, D Jorke, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 1991
Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseasesA Müller, B Krombholz, G Pott, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study]M Reinhardt, D Jorke, G Jahn, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Archiv Fur Geschwulstforschung|January 1, 1988
Results of treating stage III and IV malignant non-Hodgkin's lymphomas (NHL)H Jahn, K Ruffert, G Syrbe, et al.
Gastroenterologisches Journal : Organ Der Gesellschaft Fur Gastroenterologie Der DDR|January 1, 1989
[Resorption and biotransformation of model substances in primary idiopathic hemochromatosis (siderophilia)]A Hoffmann, A Müller, M Reinhardt, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[Epidemiology of hormone dependent malignant tumors--ovulation inhibitors and liver tumors]M Bergmann, D Jorke, G Machnik, et al.
Gastroenterologisches Journal : Organ Der Gesellschaft Fur Gastroenterologie Der DDR|January 1, 1989
[Biotransformation in patients following Depressan-induced hepatitis]A Hoffmann, M Reinhardt, C Rechenbach, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1981
[Malignant lymphomas: involvement and complications of the gastro-intestinal tract (author's transl)]D Jorke, H Jahn, K Ruffert, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1988
Enzyme activities of collagen peptidase (CP), monoaminoxidase (MAO) and N-acetyl-beta-D-glucosaminidase (beta-NAG) as fibrosis marker in chronic liver diseasesA Müller, C Zollmann, G Machnik, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1985
Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosisA Traeger, R Häntze, M Penzlin, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1985
[Emergency endoscopy in chronic liver diseases]J Truckenbrodt, H Bosseckert, D Jorke, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 1991
Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseasesA Müller, B Krombholz, G Pott, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study]M Reinhardt, D Jorke, G Jahn, et al.
Pageof 6